Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches

S Heymans, NK Lakdawala, C Tschöpe, K Klingel - The Lancet, 2023 - thelancet.com
Dilated cardiomyopathy is conventionally defined as the presence of left ventricular or
biventricular dilatation or systolic dysfunction in the absence of abnormal loading conditions …

[HTML][HTML] Role of oxidative stress and inflammation in doxorubicin-induced cardiotoxicity: A brief account

R Vitale, S Marzocco, A Popolo - International Journal of Molecular …, 2024 - mdpi.com
Cardiotoxicity is the main side effect of several chemotherapeutic drugs. Doxorubicin (Doxo)
is one of the most used anthracyclines in the treatment of many tumors, but the development …

Polyguluronic acid alleviates doxorubicin-induced cardiotoxicity by suppressing Peli1-NLRP3 inflammasome-mediated pyroptosis

E Zhang, C Shang, M Ma, X Zhang, Y Liu, S Song… - Carbohydrate …, 2023 - Elsevier
Polyguluronic acid (PG), a polysaccharide from alginate, possesses excellent bioactivities.
We prepared high-purity PG with 10.41 kDa molecular weight (Mw) and a 59 average …

[HTML][HTML] Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy

C Huang, Y Guo, T Li, G Sun, J Yang, Y Wang, Y Xiang… - Redox Biology, 2024 - Elsevier
Due to the cardiotoxicity of doxorubicin (DOX), its clinical application is limited. Lipid
peroxidation caused by excessive ferrous iron is believed to be a key molecular mechanism …

The role of inflammation and antioxidant defenses in the cardiotoxicity of doxorubicin in elderly CD-1 male mice

A Reis-Mendes, M Ferreira, JA Duarte… - Archives of …, 2023 - Springer
Doxorubicin (DOX) is a potent chemotherapeutic agent used against several cancer types.
However, due to its cardiotoxic adverse effects, the use of this drug may be also life …

Cardiomyocyte peroxisome proliferator-activated receptor α prevents septic cardiomyopathy via improving mitochondrial function

X Zhu, X Wang, S Jiao, Y Liu, L Shi, Q Xu… - Acta Pharmacologica …, 2023 - nature.com
Clinically, cardiac dysfunction is a key component of sepsis-induced multi-organ failure.
Mitochondria are essential for cardiomyocyte homeostasis, as disruption of mitochondrial …

RGS7 balances acetylation/de-acetylation of p65 to control chemotherapy-dependent cardiac inflammation

M Basak, K Das, T Mahata, D Kumar, N Nagar… - Cellular and Molecular …, 2023 - Springer
Cardiotoxicity remains a major limitation in the clinical utility of anthracycline
chemotherapeutics. Regulator of G-protein Signaling 7 (RGS7) and inflammatory markers …

Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond

M Camilli, M Viscovo, L Maggio, A Bonanni… - Basic Research in …, 2024 - Springer
Sodium–glucose cotransporter 2 inhibitors (SGLT2i), a new drug class initially designed and
approved for treatment of diabetes mellitus, have been shown to exert pleiotropic metabolic …

[HTML][HTML] Mechanistic Insights into Carvedilol's Potential Protection Against Doxorubicin-Induced Cardiotoxicity

EA Elmorsy, S Saber, RS Hamad… - European Journal of …, 2024 - Elsevier
Doxorubicin (DOX) is an anthracycline chemotherapy drug widely employed in the treatment
of various cancers, known for its potent antineoplastic properties but often associated with …

Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunction

AL Bayer, MA Zambrano, S Smolgovsky… - Nature Cardiovascular …, 2024 - nature.com
Doxorubicin, the most prescribed chemotherapeutic drug, causes dose-dependent
cardiotoxicity and heart failure. However, our understanding of the immune response elicited …